Evaluation of the Role of Exosome-derived MiRNA in Breast Cancer Diagnosis: A Systematic Review and Meta-analysis

Document Type : Review Article


1 JKKM College of Pharmacy, Tamil Nadu Dr. M.G.R Medical University, Tamil Nadu, India

2 School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3 Department of Pharmacology and Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

4 Department of Internal Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

5 Department of General Surgery, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran


Background and aim: Considering the importance of early detection of breast cancer and the use of non-invasive methods, the present study was conducted to evaluate the role of exosome-derived miRNA in breast cancer diagnosis.
Material and methods: In the present systematic review and meta-analysis, information about exosome-derived miRNA in breast cancer diagnosis in all articles published up until the end of July 2023 was collected by two trained researchers individually using keywords and combinations of keywords from databases PubMed, Scopus, Science Direct, ISI, Web of Knowledge, Elsevier, Wiley, and Embase and Google Scholar. STATA (version 17) was used to analyze data using the fixed effects model in meta-analysis; p values less than 0.05 were considered significant.
Results: A total of six studies were included in the meta-analysis process. The sensitivity and specificity of plasma-based exosomal miRNAs were 68% (ES, 95% CI: 0.39, 0.97) and 82% (ES, 95% CI: 0.52, 1.11), respectively. The sensitivity and specificity of serum-based exosomal miRNAs were 67% (ES, 95% CI: 0.33, 1.01) and 88% (ES, 95% CI: 0.54, 1.22), respectively.
Conclusions: Exosomal miRNAs have high sensitivity and specificity in breast cancer diagnosis and can be considered a valuable and promising tool for early detection of breast cancer non-invasively.


Main Subjects

[1] Houghton SC, Hankinson SE. Cancer progress and priorities: breast cancer. Cancer Epidemiology, Biomarkers & Prevention. 2021;30(5):822-44. https://doi.org/10.1158/1055-9965.EPI-20-1193.
[2] Mascara M, Constantinou C. Global perceptions of women on breast cancer and barriers to screening. Current Oncology Reports. 2021;23:1-9. https://doi.org/10.1007/s11912-021-01069-z.
[3]Narayan AK, Lee CI, Lehman CD. Screening for breast cancer. Medical Clinics. 2020;104(6):1007-21. https://doi.org/10.1016/j.mcna.2020.08.003.
[4] Ginsburg O, Yip CH, Brooks A, Cabanes A, Caleffi M, Dunstan Yataco JA, et al. Breast cancer early detection: A phased approach to implementation. Cancer. 2020;126(s10):2379-93. https://doi.org/10.1002/cncr.32887.
[5] Hashemipour M, Boroumand H, Mollazadeh S, Tajiknia V, Nourollahzadeh Z, Borj MR, et al. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers. Gynecologic oncology. 2021;161(1):314-27. https://doi.org/10.1016/j.ygyno.2021.02.004.
[6] Babaei K, Shams S, Keymoradzadeh A, Vahidi S, Hamami P, Khaksar R, et al. An insight of microRNAs performance in carcinogenesis and tumorigenesis; an overview of cancer therapy. Life sciences. 2020;240:117077. https://doi.org/10.1016/j.lfs.2019.117077.
[7] Chung IM, Rajakumar G, Venkidasamy B, Subramanian U, Thiruvengadam M. Exosomes: Current use and future applications. Clinica Chimica Acta. 2020;500:226-32. https://doi.org/10.1016/j.cca.2019.10.022.
[8] O’Brien K, Breyne K, Ughetto S, Laurent LC, Breakefield XO. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nature reviews Molecular cell biology. 2020;21(10):585-606. https://doi.org/10.1038/s41580-020-0251-y.
[9] Bryzgunova O, Konoshenko M, Zaporozhchenko I, Yakovlev A, Laktionov P. Isolation of cell-free mirna from biological fluids: Influencing factors and methods. Diagnostics. 2021;11(5):865. https://doi.org/10.3390/diagnostics11050865.
[10] Wu J, Shen Z. Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer. Cancer medicine. 2020;9(19):6909-22.
[11] Ghaemmaghami AB, Mahjoubin-Tehran M, Movahedpour A, Morshedi K, Sheida A, Taghavi SP, et al. Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis. Cell Communication and Signaling. 2020;18:1-9. https://doi.org/10.1186/s12964-020-00623-9.
[12] Wang S, Yang Y, Sun L, Qiao G, Song Y, Liu B. Exosomal microRNAs as liquid biopsy biomarkers in hepatocellular carcinoma. OncoTargets and therapy. 2020;(13):2021-30. https://doi.org/10.2147/OTT.S232453.
[13] Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European journal of epidemiology. 2010;25:603-5. https://doi.org/10.1007/s10654-010-9491-z.
[14] Asgari R, Rezaie J. Differential expression of serum exosomal miRNAs in breast cancer patients and healthy controls. Advanced Pharmaceutical Bulletin. 2022;12(4):858-62. https://doi.org/10.34172/apb.2022.088.
[15] Zhou J, Jiang Z, Yoo JH, Hwang JN. Hierarchical pose classification for infant action analysis and mental development assessment. InICASSP 2021-2021 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP) 2021;6:1340-44. https://doi.org/10.1109/ICASSP39728.2021.9415088.
[16] 周永刚, 李者龙, 邢长洋, 杨泽利, 金京兰, 袁丽君. 血浆外泌体 microRNA-6886 和 microRNA-6819 在乳腺肿块良恶性鉴别诊断中的价值. Progress in Modern Biomedicine. 2021;21(20):3898. https://doi.org/10.13241/j.cnki.pmb.2021.20.019.
[17] Liu M, Mo F, Song X, He Y, Yuan Y, Yan J, et al. Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis. PeerJ. 2021;9:e12147. https://doi.org/10.7717/peerj.12147.
[18] Li D, Wang J, Ma LJ, Yang HB, Jing JF, Jia MM, et al. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer. European Review for Medical & Pharmacological Sciences. 2020;24(13):7303-09.
[19] Lv S, Wang Y, Xu W, Dong X. Serum Exosomal miR-17-5p as a Promising Biomarker Diagnostic Biomarker for Breast Cancer. Clinical Laboratory. 2020;(9):1823-34.
[20] Lowry MC, Gallagher WM, O'Driscoll L. The role of exosomes in breast cancer. Clinical chemistry. 2015;61(12):1457-65. https://doi.org/10.1373/clinchem.2015.240028.
[21] Bhat SA, Majid S, Hassan T. Advances in Biomarker Sciences and Technology.2019:1-8. https://doi.org/10.1016/j.abst.2019.05.001.